Hepatitis B virus (HBV) is a human hepatotropic virus. However, HBV infection also occurs at extrahepatic sites, but the relevant host factors required for HBV infection in non-hepatic cells are only partially understood. In this article, a non-hepatic cell culture model is constructed by exogenous expression of four host genes (NTCP, HNF4α, RXRα and PPARα) in human non-hepatic 293T cells. This cell culture model supports HBV entry, transcription and replication, as evidenced by the detection of HBV pgRNA, HBV cccDNA, HBsAg, HBeAg, HBcAg and HBVDNA. Our results suggest that the above cellular factors may play a key role in HBV infection of nonhepatic cells. This model will facilitate the identification of host genes that support extrahepatic HBV infection. K E Y W O R D S HBV, HNF4α, non-hepatic cells, NTCP, nuclear hormone receptors, PPARα, RXRα S U PP O RTI N G I N FO R M ATI O N Additional supporting information may be found online in the Supporting Information section. How to cite this article: Yang X, Cai W, Sun X, et al. Defined host factors support HBV infection in non-hepatic 293T cells. J
| INTRODUC TI ON
Hepatitis B is one of the major diseases of mankind and affects the lives of more than 2 billion people. WHO estimates that in 2015, approximately 257 million people were chronically infected with hepatitis B virus (HBV) worldwide, causing about 887 000 deaths per year due to HBV-associated liver pathologies. 1 Since drugs for HBV treatment can reduce HBV replication, but rarely result in complete cure, HBV-related liver diseases remain a major public health problem. 2, 3 As a human hepatotropic virus, HBV mainly replicates in and damages the human liver, but at the same time, HBV infects other cell types in extrahepatic tissues, such as lymph nodes, spleen, kidney, periadrenal ganglia and testis. 4, 5 HBV viral replication in these tissues plays an important role in the pathogenesis of extrahepatic syndromes. 6 Our research group previously reported the existence of HBV DNA in the chromosomes of sperm isolated from chronic hepatitis B patients. HBV genes can also be expressed in early embryonic cells originating from hamster oocytes fertilized with human spermatozoa transfected with the complete viral genome, 7, 8 and HBV infection can adversely affect human sperm due to HBV S protein-mediated loss of sperm mitochondrial membrane potential, resulting in reduced sperm motility. 9 However, we found that the asialoglycoprotein receptor (ASGR) was not expressed in human testis, suggesting that HBV might invade spermatogonial cells through other receptors. 10 Although such restricted non-hepatic infection of HBV has been observed, the host factors required for HBV infection in non-hepatic cells remain only partially understood.
Currently, cell culture models for studying extrahepatic HBV infection are limited. Hepatoma-based cell culture models, such as HepG2 and Huh7, are widely used in HBV research. However, it is not an easy task to identify key factors in HBV infection from a vast number of liver-enriched genes expressed in these human hepatoma cells. Reconstitution of HBV infection in non-hepatic cells will identify host factors that support HBV entry, transcription and replication. Up to now, multiple factors related to HBV infection and replication have been discovered. HBV entry can be mediated by heparan sulphate proteoglycan (HSPG) such as Glypican-5 (GPC5), sodium taurocholate co-transporting polypeptide (NTCP). [11] [12] [13] [14] HBV transcription is also regulated by liver-enriched transcriptional factors such as hepatocyte nuclear factors (HNF) including HNF1, HNF3 and HNF4, CCAAT/enhancer-binding protein (C/EBP), and nuclear hormone receptors such as RXRa and PPARa. 11, [15] [16] [17] [18] The initial step of HBV infection involves binding of the virus to a receptor on the target cell surface and initiating viral entry. The preS1 domain of HBV mediates attachment of the virus to its target cell. 19 HBV particles bind the ASGR in a process that is inhibited by preS1, 20 indicating ASGR facilitates HBV infection. 21 In addition, HSPG (eg, GPC5)
is required for the first steps of HBV infection. 12, 13, 22 Recent reports suggest the sodium taurocholate co-transporting polypeptide (NTCP) to be a functional HBV cell entry factor. NTCP physically interacts with the N-terminal domain of preS1 and mediates viral entry into hepatocytes. Most recently, epidermal growth factor receptor has been discovered to play a critical role in mediating HBV-NTCP internalization into hepatocytes. 23 With the identification of the receptor, hepatoma cell lines that overexpress NTCP are susceptible to HBV infection. 14, 24 As a bile salt transporter, NTCP is strongly expressed in parenchymal liver cells and is localized to the sinusoidal membrane. 25 The expression NTCP in human non-hepatic cells and hepatoma cells is lower than in human primary hepatocytes, which will limit HBV entry into these cells. Moreover, cell lines of non-hepatic origin do not independently support HBV replication due to a deficiency of some liver-enriched transcription factors. HBV pregenomic RNA (pgRNA) cannot be detected even when HBV-containing plasmids are transfected into mouse non-hepatic NIH3T3 cells. 18, 26 Liver-enriched transcription factors, such as hepatocyte factor and retinoid X receptor α (RXRα), can bind to HBV promoters and regulate the transcription of HBV genes. 27 Nuclear hormone receptors (HNF4α, RXRα, PPARα) are essential for pgRNA synthesis and viral replication. 18, 27, 28 To reconstitute HBV infection in non-hepatic cells, we ectopically express multiple genes participating in HBV entry, transcription and replication. In this study, we show that co-expression of the nuclear hormone receptors HNF4α, RXRα and PPARα, and the HBV receptor NTCP support the entry and replication of HBV in 293T cells.
This model will facilitate the study of HBV infection in non-hepatic cells as well as host factors required for liver tropism of HBV. 
| MATERIAL S AND ME THODS

| Plasmid constructs
| Cells and generation of stable cell line
| Cell transfection
| Lentivirus preparation
Lentiviral vectors individually encoding the three nuclear hormone receptors (HNF4α, RXRα, and PPARα) and human NTCP were constructed. Then, lentivirus was produced through HEK293T transfection and concentrated by using a Lenti-X™ Concentrator kit (cat.631231, Clontech). 30 Titrations were quantified by qPCR to be 5.82 × 10 7 TU/mL (hNTCP), 3.36 × 10 7 TU/mL (HNF4α), 6.61 × 10 7 TU/mL (PPARα), and 9.06 × 10 6 TU/mL (RXRα). 31 After that, lentivirus was used to transduce 293T cells, followed by selection with 1.0 μg/mL puromycin. Gene).All cells were cultured in 24-well collagen-coated plates maintained in DMEM/F-12(Gibco) medium supplemented with 10% FBS, 4 mmol/L Glutamax, 0.1 mmol/L NEAA, 1 mmol/L sodium pyruvate, 100 U/mL penicillin, 100 μg/mL streptomycin, 1 mg/mL puromycin, 40 ng/mL dexamethasone, 20 μg/mL hydrocortisone, and 5 μg/mL insulin. We inoculated HBV with an indicated genome equivalents (GEq)/cell in medium containing 4% PEG8000 (Sigma-Aldrich) and 2% DMSO (Sigma-Aldrich) to the cells (over 90% confluent) for 24 hours at 37°C. After 24 hours infection, we remove the HBV inocula and washed the cells three times with PBS. The medium was changed every 2 days. Supernatant and cells were harvested at the indicated time. For replication inhibition, cells were incubated with 0.2 mg/mL lamivudine (LAM) (GlaxoSmithKline). For entry inhibition, cells were incubated with 5 μmol/L cyclosporine A (CsA) (BBI).
| HBV preparation and infection
| Quantitative PCR analysis of HBV cccDNA
To selectively extract HBV cccDNA, transfected or infected cells 
| RT-qPCR
Total RNA was extracted using an RNeasy Mini Kit (Qiagen). About 1000 ng of total RNA was reverse transcribed into cDNA with an RT-PCR Kit (FSQ-101, TOYOBO), and qPCR was performed using 2× Power SYBR Green Master Mix (Applied Biosystems) and an ABI 7500 machine, with GAPDH for normalization of input RNA. The RT-qPCR data were analysed by the ΔΔCT method. Primer sequences are listed in Table 1 .
| Time-resolved immunofluorometric assay (TRIFA)
Cell supernatants containing HBV particles were filtered through a 
| ELISA
The supernatants were harvested and used to determine the concentrations of HBsAg and HBeAg using ELISA test kits (KeHua) following the manufacturer's instruction. Absorbance was determined with a microtitre plate reader (Quant, Biotek) by dual-wavelength measurement (450/630 nm). 
| Immunofluorescence
| Western blotting
293T and 293T-NE-3NRs cells were washed 3 times with PBS and lysed on ice in RIPA buffer containing 1% protease inhibitor cocktail (Millipore). Protein concentration was determined by a BCA protein assay kit (Beyotime). Protein were electrophoresed on 10% SDS-PAGE and transferred to a PVDF membrane (Millipore). Then, the membrane was incubated overnight at 4°C with anti-HNF4α (Sigma-Aldrich), anti-PPARα (Thermo Fisher), anti-RXRα (Sigma-Aldrich), anti-SLC10A1 (anti-NTCP, Sigma-Aldrich) or anti-β-actin (Sigma-Aldrich), respectively. Proteins were detected by enhanced chemiluminescence (Pierce) and exposed to X-ray film.
| Statistics
All experiments were conducted three times in an independent manner and results are shown as mean ± SD (n = 3). All data are normally distributed, and statistical analyses were performed by GraphPad with the nucleoside analog-adefovir dipivoxil, to inhibit HBV replication, also reduced HBV pgRNA and HBsAg ( Figure S1 ).
| RE SULTS
| Nuclear hormone receptors activate HBV replication in 293T cells
| NTCP-EGFP mediates the entry of HBV into HepG2-NTCP-EGFP cells
Recently, it was found that susceptibility to HBV infection is determined by NTCP, a functional receptor for HBV entry. 14 Figure 2C ). Furthermore, HepG2-NTCP-
EGFP cells supported productive infection based on immunostain-
ing for HBV core (HBc) protein ( Figure 2D ). These results suggest that ectopic expression of NTCP-EGFP in HepG2 cells also enables cells to be infected by HBV.
| Productive HBV infection of 293T cells requires expression of NTCP, HNF4α, RXRα and PPARα
As we showed above (Figures 1 and 2 Figure S3 ).
| HBV infection occurs in the modified 293T cells co-cultured with HepG2.2.15
In the above HBV infection at high GEq/cell (150), DMSO and PEG8000 were used to increase HBV infection efficiency, and the virus was mouse hepatoma cell lines. 35, 36 In addition, human lung epithelial cells (A549) overexpressing NTCP also do not support HBV infection. 37 These results suggested that NTCP expression alone is not sufficient to confer HBV infection and that additional liver-specific factors are required.
In this study, we reconstituted HBV infection in human embryonic 293T cells by ectopic co-expression of the nuclear hormone receptors HNF4α, RXRα and PPARα, and the HBV receptor NTCP.
The first barrier to HBV infection in non-hepatic cells is a lack of a hepatocyte-specific virus receptor, now known as NTCP. 14 In summary, we have engineered human embryonic kidney cells (293T), competent for replicating HBV, by expressing liver-enriched genes necessary for HBV entry and transcription.
We demonstrate that susceptibility to HBV can be conferred to 
